ZJYL vs. TMCI, SMLR, NNOX, CLPT, TCMD, DCTH, ZIMV, CVRX, NPCE, and SMTI
Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include Treace Medical Concepts (TMCI), Semler Scientific (SMLR), Nano-X Imaging (NNOX), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), NeuroPace (NPCE), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry.
Jin Medical International vs.
Jin Medical International (NASDAQ:ZJYL) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.
Jin Medical International has a beta of 13.62, suggesting that its share price is 1,262% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.
Jin Medical International has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -30.33%. Jin Medical International's return on equity of 0.00% beat Treace Medical Concepts' return on equity.
In the previous week, Treace Medical Concepts had 1 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Treace Medical Concepts and 3 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.34 beat Treace Medical Concepts' score of 0.16 indicating that Jin Medical International is being referred to more favorably in the media.
Treace Medical Concepts received 25 more outperform votes than Jin Medical International when rated by MarketBeat users.
Jin Medical International has higher earnings, but lower revenue than Treace Medical Concepts.
Treace Medical Concepts has a consensus target price of $8.98, suggesting a potential upside of 3.14%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts clearly believe Treace Medical Concepts is more favorable than Jin Medical International.
84.1% of Treace Medical Concepts shares are held by institutional investors. 24.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Treace Medical Concepts beats Jin Medical International on 8 of the 15 factors compared between the two stocks.
Get Jin Medical International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jin Medical International Competitors List
Related Companies and Tools
This page (NASDAQ:ZJYL) was last updated on 1/21/2025 by MarketBeat.com Staff
